Eosinophilic cryptitis and crypt abscess associated with clozapine: a case report
Frontiers in Psychiatry · 16.11.2026 · 17
DOI: 10.3389/fpsyt.2026.1997733 ↗Kurz gefasst
Fallbericht in der Zeitschrift Frontiers in Psychiatry, online erschienen am 16.11.2026. Verfasst von Edmund Xiu Ming Chong und 2 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Clozapine has been consistently found to be superior to other antipsychotic medications for the treatment of treatment-resistant schizophrenia, specifically in improving persistent psychotic symptoms. It is also associated with an improved quality of life as well as lower hospitalization rates, reduced suicidality, and premature mortality. Despite its lower risk of extrapyramidal side effects (EPS), clozapine is not considered first-line treatment for schizophrenia due to its array of adverse reactions. Rarely, clozapine may cause eosinophilia. We present a case of a 24-year-old Asian patient with treatment-resistant schizophrenia who developed eosinophilic cryptitis and crypt abscess after initiation of clozapine.
Zitieren
APA
Chong, E. X. M., Abraham, N. J., & Teoh, S. Y. (2026). Eosinophilic cryptitis and crypt abscess associated with clozapine: a case report. Frontiers in Psychiatry, 17. https://doi.org/10.3389/fpsyt.2026.1997733
Vancouver
Chong EXM, Abraham NJ, Teoh SY. Eosinophilic cryptitis and crypt abscess associated with clozapine: a case report. Frontiers in Psychiatry. 2026;17. doi:10.3389/fpsyt.2026.1997733
BibTeX
@article{Chong2026,
author = {Chong, Edmund Xiu Ming and Abraham, Nicholas Jeyanesan and Teoh, Sue Ying},
title = {Eosinophilic cryptitis and crypt abscess associated with clozapine: a case report},
journal = {Frontiers in Psychiatry},
year = {2026},
volume = {17},
doi = {10.3389/fpsyt.2026.1997733}
}
EUVIMED